echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Announcement of the State Food and Drug Administration on the cancellation of 226 drug registration certificates including bromelain enteric-coated tablets (No. 27 of 2021)

    Announcement of the State Food and Drug Administration on the cancellation of 226 drug registration certificates including bromelain enteric-coated tablets (No. 27 of 2021)

    • Last Update: 2021-07-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to the "Regulations for the Implementation of the Drug Administration Law of the People's Republic of China" and the "Administrative Measures for Drug Registration", the State Drug Administration has decided to cancel 226 drug registration certificates including bromelain enteric-coated tablets


    Hereby announce



    Attachment: Catalogue of Cancellation of Drug Registration Certificate


    State Food and Drug Administration

    February 23, 2021




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.